Table 1. Comparison of measured clinical and laboratory parameters of the FDRs of patients with chronic kidney disease and the controls.
| Variables | FDRs (n = 230) | Controls (n = 230) | p-value |
| Mean age (years) | 33.49 ± 12.0 | 33.67 ± 12.2 | 0.87 |
| Mean SBP (mmHg) | 116.5 ± 22.5 | 112.1 ± 18.1 | 0.02* |
| Mean DBP (mmHg) | 74.9 ± 12.7 | 71.4 ± 10.5 | 0.01* |
| Mean BMI (kg/m2) | 25.5 ± 5.3 | 23.8 ± 4.0 | 0.01* |
| Mean WC (cm) | 81.8 ± 13.3 | 79.3 ± 11.3 | 0.03* |
| Mean HC (cm) | 100.0 ± 11.3 | 98.4 ± 11.5 | 0.13 |
| Mean SCr (μmol/l) | 89.9 ± 23.4 | 88.3 ± 21.1 | 0.42 |
| Mean FPG (mmol/l) | 4.3 ± 1.1 | 4.3 ± 0.9 | 0.79 |
| Mean SUA (μmol/l) | 239.9 ± 99.4 | 237.4 ± 81.3 | 0.85 |
| Mean TC (mg/dl) | 146.5 ± 51.0 | 147.8 ± 40.1 | 0.24 |
| (mmol/l) | (3.79 ± 1.32) | (3.83 ± 1.04) | |
| Mean HDL-C (mg/dl) | 30.8 ± 10.5 | 34.7 ± 12.6 | 0.10 |
| (mmol/l) | (0.8 ± 0.27) | (0.9 ± 0.33) | |
| Mean LDL-C (mg/dl) | 106.7 ± 42.3 | 107 ± 38.2 | 0.41 |
| (mmol/l) | (2.76 ± 1.10) | (2.77 ± 0.99) | |
| Mean TG (mg/dl) | 95.1 ± 22.8 | 92.3 ± 24.3 | 0.06 |
| (mmol/l) | (1.07 ± 0.26) | (1.04 ± 0.27) | |
| Mean eGFR (ml/min/1.73 m2) | 106.6 ± 28.3 | 102.3 ± 25.0 | 0.09 |
| Mean urine ACR | 22.1 (0.5–1.406) | 18.2 (0.6–1.296) | 0.02* |
ACR, albumin:creatinine ratio; BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FDRs, first-degree relatives of patient with chronic kidney disease; FPG, fasting plasma glucose; HC, hip circumference; HDL-C, high-density lipoprotein cholesterol; LDL-C, lowdensity lipoprotein cholesterol; SCr, serum creatinine; SUA, serum uric acid; TG, triglyceride; WC, waist circumference.